tiprankstipranks
Trending News
More News >
Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX
US Market

Forte Biosciences (FBRX) Income Statement

Compare
323 Followers

Forte Biosciences Income Statement

Last quarter (Q3 2025), Forte Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Forte Biosciences's net income was $-17.68M. See Forte Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -39.00K$ -9.00K$ 0.00$ -36.00K$ -54.00K
Operating Expenses
$ 36.56M$ 32.48M$ 13.90M$ 21.49M$ 14.17M
Depreciation and Amortization
$ 39.00K$ 9.00K$ 36.00K$ 36.00K$ 54.00K
EBITDA
$ -35.44M$ -32.48M$ -13.86M$ -21.45M$ -46.43M
Operating Income
$ -36.60M$ -32.49M$ -13.90M$ -21.49M$ -14.22M
Other Income/Expenses
$ 1.12M$ 1.01M$ 17.00K$ -222.00K$ -32.26M
Pretax Income
$ -35.48M$ -31.48M$ -13.88M$ -21.71M$ -46.49M
Net Income
$ -35.48M$ -31.48M$ -13.86M$ -21.71M$ -46.49M
Per Share Metrics
Basic EPS
$ -12.17$ -24.92$ -19.96$ -38.85$ -157.93
Diluted EPS
$ -12.17$ -24.92$ -19.96$ -38.85$ -157.93
Weighted Average Shares Outstanding
2.92M 1.26M 695.34K 558.71K 294.36K
Weighted Average Shares Outstanding (Diluted)
2.92M 1.26M 695.34K 558.71K 294.36K
Currency in USD

Forte Biosciences Earnings and Revenue History